Cliff Asness's BNTC Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 22,481 shares of Benitec Biopharma Inc. (BNTC) worth $300,796, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Cliff Asness has initiated a new position in BNTC, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Benitec Biopharma (BNTC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Benitec Biopharma (BNTC) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +22,481 | New Buy | 22,481 | $13.38 |
Cliff Asness's Benitec Biopharma Investment FAQs
Cliff Asness first purchased Benitec Biopharma Inc. (BNTC) in Q2 2026, acquiring 22,481 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Benitec Biopharma Inc. (BNTC) for 1 quarters since Q2 2026.
Cliff Asness's largest addition to Benitec Biopharma Inc. (BNTC) was in Q2 2026, adding 22,481 shares worth $300,796.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 22,481 shares of Benitec Biopharma Inc. (BNTC), valued at approximately $300,796.
As of the Q2 2026 filing, Benitec Biopharma Inc. (BNTC) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Benitec Biopharma Inc. (BNTC) was 22,481 shares, as reported at the end of Q2 2026.